cGMP Deviations
H J Harkins Company Inc
Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle
CGMP Deviations: Presence of NDMA impurity detected in product.
CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
CGMP Deviations:Traces amounts of N-Nitroso N-Methyl 4- amino butyric acid (NMBA) impurity found in Active Pharmaceutical Ingredient (API).
Presence of Particulate Matter: Crystalline particles were noticed by manufacturer at the 24 month clarity testing.
Carcinogen impurity detected in API used to manufacture drug product.